We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
+26.3%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$12.9B
AUM Growth
+$151M
(+1.2%)
Cap. Flow
-$2.53B
Cap. Flow
% of AUM
-19.61%
Top 10 Holdings %
Top 10 Hldgs %
34.42%
Holding
917
New
232
Increased
199
Reduced
245
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$344M |
| 2 |
Vale
VALE
|
+$168M |
| 3 |
AT&T
T
|
+$137M |
| 4 |
S&P Global
SPGI
|
+$131M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$416M |
| 2 |
Microsoft
MSFT
|
+$406M |
| 3 |
Merck
MRK
|
+$180M |
| 4 |
Starbucks
SBUX
|
+$165M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.33% |
| 2 | Technology | 11.78% |
| 3 | Healthcare | 9.81% |
| 4 | Financials | 9.42% |
| 5 | Industrials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
iShares Russell 1000 Growth ETF
IWF
$122B
| $4.13M | 0.03% |
86,068
+7,024
| +9% | +$310K |
|
|
WRK
327
DELISTED
WestRock Company
WRK
| $4.12M | 0.03% |
145,772
+16,826
| +13% | +$478K |
|
|
WWE
328
DELISTED
World Wrestling Entertainment
WWE
| $4.11M | 0.03% |
+94,600
| New | +$4.06M |
|
329
Crown Castle
CCI
$32.7B
| $4.04M | 0.03% |
24,119
-58,287
| -71% | -$9.39M |
|
330
Agilent Technologies
A
$39.1B
| $4.01M | 0.03% |
45,352
-232,761
| -84% | -$19.1M |
|
331
SEI Investments
SEIC
$11.9B
| $3.98M | 0.03% |
+72,307
| New | +$3.78M |
|
332
Nu Skin
NUS
$247M
| $3.96M | 0.03% |
+103,700
| New | +$3.33M |
|
|
ABMD
333
DELISTED
Abiomed Inc
ABMD
| $3.91M | 0.03% |
16,191
-6,403
| -28% | -$1.29M |
|
334
W.W. Grainger
GWW
$65.3B
| $3.9M | 0.03% |
+12,418
| New | +$3.59M |
|
335
Palo Alto Networks
PANW
$264B
| $3.85M | 0.03% |
100,446
-30,774
| -23% | -$1.08M |
|
336
iShares MSCI Malaysia ETF
EWM
$305M
| $3.81M | 0.03% |
151,200
+35,000
| +30% | +$855K |
|
|
BHVN
337
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $3.64M | 0.03% |
+49,789
| New | +$2.65M |
|
338
Old Republic International
ORI
$10.3B
| $3.62M | 0.03% |
+222,000
| New | +$3.51M |
|
339
Zimmer Biomet
ZBH
$17.7B
| $3.56M | 0.03% |
30,695
-71,945
| -70% | -$8.29M |
|
340
MarketAxess Holdings
MKTX
$4.15B
| $3.55M | 0.03% |
7,093
-12,208
| -63% | -$5.69M |
|
341
Conagra Brands
CAG
$7.07B
| $3.55M | 0.03% |
+100,914
| New | +$3.36M |
|
342
Iron Mountain
IRM
$38.2B
| $3.52M | 0.03% |
134,841
+20,889
| +18% | +$527K |
|
|
TTM
343
DELISTED
Tata Motors Limited
TTM
| $3.52M | 0.03% |
534,994
-50,538
| -9% | -$291K |
|
|
BKI
344
DELISTED
Black Knight, Inc. Common Stock
BKI
| $3.5M | 0.03% |
48,293
+11,288
| +31% | +$800K |
|
345
Invesco Ultra Short Duration ETF
GSY
$3.82B
| $3.47M | 0.03% |
68,716
| – | – |
|
346
iShares Russell 1000 Value ETF
IWD
$82B
| $3.39M | 0.03% |
30,137
+2,147
| +8% | +$236K |
|
347
Robert Half
RHI
$3.61B
| $3.3M | 0.03% |
62,440
+31,945
| +105% | +$1.52M |
|
348
iShares China Large-Cap ETF
FXI
$4.31B
| $3.27M | 0.03% |
82,281
-134,391
| -62% | -$5.24M |
|
349
Annaly Capital Management
NLY
$16.9B
| $3.24M | 0.03% |
123,474
+117,966
| +2,142% | +$2.91M |
|
350
Ollie's Bargain Outlet
OLLI
$4.01B
| $3.21M | 0.03% |
+32,913
| New | +$2.53M |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q2 2020 Portfolio in Review
As of Q2 2020, Natixis held 917 positions worth $12.9B, up 1.2% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Natixis withdrew a net $2.53B in Q2 2020, closing 202 positions and reducing 245 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $155M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Natixis opened a new position in S&P Global worth $144M.
- Natixis's largest Q2 2020 buy was S&P Global: 436,534 shares worth $144M.
- Natixis added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $344M increase.
- Natixis's biggest Q2 2020 reduction was Apple, cutting an estimated $416M.
- Natixis fully exited State Street SPDR S&P Biotech ETF in Q2 2020, selling an estimated $155M.
- Natixis's ten largest holdings make up 34% of its $12.9B portfolio in Q2 2020.
- Natixis opened 232 new positions and closed 202 in Q2 2020.
- Natixis's portfolio value rose 1.2% quarter-over-quarter to $12.9B.
Based on Natixis's 13F filing for Q2 2020, filed 13 Aug 2020.